We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $1.63M
1-Year Est. Return 7.5%
This Fund
S&P 500
This Quarter Est. Return
+11.54%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
10 Year Est. Return
AUM
$177M
AUM Growth
+$66.1M
Cap. Flow
+$68.9M
Cap. Flow %
38.92%
Top 10 Hldgs %
50.27%
Holding
262
New
77
Increased
16
Reduced
22
Closed
67

Similar funds

Fifth Lane Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Fifth Lane Capital held 262 positions worth $177M, up 60% from $111M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Fifth Lane Capital deployed $68.9M of net new capital in Q1 2023, opening 77 new positions and adding to 16 existing holdings. Its largest new stake was L Catterton Asia Acquisition Corp Class A Ordinary Shares: 900,000 shares worth $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, up from 7.4% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $4.61M trimmed.

  • Fifth Lane Capital's largest Q1 2023 buy was L Catterton Asia Acquisition Corp Class A Ordinary Shares: 900,000 shares worth $9.2M.
  • Fifth Lane Capital added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $9.95M increase.
  • Fifth Lane Capital's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $4.61M.
  • Fifth Lane Capital fully exited Meridian Bioscience Inc in Q1 2023, selling an estimated $6.17M.
  • Fifth Lane Capital's ten largest holdings make up 50% of its $177M portfolio in Q1 2023.
  • Fifth Lane Capital opened 77 new positions and closed 67 in Q1 2023.
  • Fifth Lane Capital's portfolio value rose 60% quarter-over-quarter to $177M.

Based on Fifth Lane Capital's 13F filing for Q1 2023, filed 15 May 2023.